Abrams, R. (1975) What's new in convulsive therapy? In: New dimensions in psychiatry, ed. Arieti, S. & Chronzanowski, G.. Wiley. [aNRs]Google Scholar

Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C. & Freedman, R. (1982) Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry 17:639–46 [rNRS]Google Scholar

Adler, L. E., Rose, G. & Freedman, R. (1986) Neurophysiological studies of sensory gating in rats: Effects of amphetamine, phencyclidine, and haloperidol. Biological Psychiatry 21:787–98. [rNRS]CrossRefGoogle ScholarPubMed

Akert, K. (1964) Comparative anatomy of the frontal cortex and thalamocortical connections. In: The frontal and granular cortex and behaviour, ed. Warren, J. M. & Akert, K.. McGraw-Hill. [JPT]Google Scholar

Akiskal, H. S. & McKinney, W. T. Jr (1975) Overview of recent research in depression. Archives ofCeneral Psychiatry 30:285. [aNRS]CrossRefGoogle Scholar

Alarcon, R. & De Carney, M. (1969) Severe depressive mood changes following slow release intramuscular fluphenazine injection. British Medical Journal 3:564. [arNRS]CrossRefGoogle ScholarPubMed

Albus, M., Ackenheil, M., Munch, U. & Naber, D. (1984) Ceruletide: A new drug for the treatment of schizophrenic patiens? Archives of General Psychiatry 41:528. [rNRS]CrossRefGoogle Scholar

Alfredsson, G., Harnryd, C. & Wiesel, F. A. (1985) Effects of sulpiride and chlorpromazine on autistic and positive symptoms in schizophrenic patients: Relationship to drug concentrations. Psychopharmacology 85:8–13. [PS]CrossRefGoogle ScholarPubMed

Alheid, C. F. & Heimer, L. (1985) The ventral-striato-pallidal (VSP) system and the substantia innominate (SI) complex of the rat. Abstract presented at Symposium: The neural and metabolic bases of feeding. Appetite 6:198. [GFA]Google Scholar

Alkon, D. L. (1983) Learning in a marine snail. Scientific American 7:70–84. [DLC]CrossRefGoogle Scholar

Allen, A. & Rosse, R. B. (1986) Hospital evaluation and treatment of dementia. Resident & Staff Physician 32:71–77. [rNRS]Google Scholar

American Medical Association (1985) Consensus conference: Electroconvulsive therapy. Journal of the American Medical Association 254:2103–8. [aNRS]CrossRefGoogle Scholar

American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders. American Psychiatric Association. [aNRS]Google Scholar

Amsel, A. (1962) Frustrative nonreward in partial reinforcement and discrimination learning: Some recent history and a theoretical extension. Psychological Review 69:306–28. [JAG]CrossRefGoogle Scholar

Amsterdam, J. D., Winokur, A., Lucki, I., Caroff, S., Snyder, P. & Rickels, K. (1983) A neuroendocrine test battery in bipolar patients and healthy subjects. Archives ofCeneral Psychiatry 40:515–22. [aNRS]CrossRefGoogle ScholarPubMed

Anden, N. E. (1977) Functional effects of local injections of dopamine and analogs into the neostriatum and nucleus accumbens. Advances in Biochemical Psychopharmacology 16:385–39. [AEK]Google ScholarPubMed

Andreasen, N. C., Nasrallah, H. A., Dunn, V., Olson, S. C., Grove, W. M., Ehrhardt, J. A., Coffman, J. A. & Crossett, J. H. W. (1986) Structural abnormalities in the frontal system in schizophrenia. Archives of General Psychiatry 43:136–47. [AEK]CrossRefGoogle ScholarPubMed

Andreasen, N. C. & Olsen, S. (1982) Negative and positive schizophrenia: Definition and validation. Archives of General Psychiatry 39: 789–94. [PS]CrossRefGoogle ScholarPubMed

Anisman, H., Irwin, J. & Sklar, L. S. (1979) Deficits of escape performance following catecholamine depletion: Implications for behavioral deficits induced by uncontrollable stress: Psychopharmacology 64:163–70. [aNRS]CrossRefGoogle ScholarPubMed

Anisman, H., Remington, G. & Sklar, L. S. (1979) Effects of inescapable shock on subsequent escape performance: Catecholaminergic and cholinergic mediation of response initiation and maintenance. Psychopharmacology 61:107–24. [aNRS]CrossRefGoogle ScholarPubMed

Anisman, H., Suissa, A. & Sklar, L. S. (1980) Escape deficits induced by uncontrollable stress: Antagonism by dopamine and noradrenaline agonists. Behavioral and Neural Biology 28:34–47. [aNRS]CrossRefGoogle ScholarPubMed

Arluison, M., Agid, Y. & Javoy, F. (1978) Dopaminergic nerve endings in the neostriatum of the rat. I. Identification by intracerebral injections of 5 hydroxydopamine. Neurosdence 3:657–73. [JHF]CrossRefGoogle Scholar

Bak, I. J., Choi, W. B., Hessler, R., Usunoff, K. G. & Wagner, A. (1975) Fine structural synaptic organization of the corpus striatum and substantia nigra in rat and cat. In: Dopaminergic mechanisms, ed. Calne, D., Chase, T. & Barbeau, A.. Raven Press. [JHF]Google Scholar

Baldessarini, R. J. (1977) Chemotherapy in psychiatry. Harvard University Press. [AAG]Google Scholar

Baldessarini, R. J. & Tarsy, D. (1980) Dopamine and the pathophysiology of dyskinesias induced by antipsychotic drugs. Annual Review of Neurosdence 3:23–41. [aNRS]CrossRefGoogle ScholarPubMed

Ballenger, J. C. & Post, R. M. (1980) Carbamazepine in manic-depressive illness: A new treatment. American Journal of Psychiatry 137:782–90. [aNRS]Google ScholarPubMed

Bank, B., Coulter, D., Rasmussen, H., Chute, D. L. & Alkon, D. L. (1986) Effects of NMR conditioning on intracellular distribution of protein kinase C. Society for Neurosdence Abstracts (51.9) 1:182. [DLC]Google Scholar

Bank, B., Gurd, J. & Chute, D. L. (1986) Decreased phosphorylation of synaptic glycoproteins following hippocampal kindling. Brain Research 399:390–94. [DLC]CrossRefGoogle ScholarPubMed

Bannon, M. J., Michaud, R. L. & Roth, R. H. (1981) Mesocortical dopamine neurons: Lack of autoreceptors modulating dopamine synthesis. Molectdar Pharmacology 19:270–75. [GEJ]Google ScholarPubMed

Bannon, M. J. & Roth, R. H., (1983) Pharmacology of mesocortical dopamine neurons. Pharmacological Reviews 35:53–68. [GEJ]Google ScholarPubMed

Bartholini, C., Scatton, B., Worms, P., Zivkovic, B. & Lloyd, K. G. (1981) Interactions between GABA, dopamine, acetylcholine and glutamatecontaining neurons in the extrapyramidal and limbic systems. In: GABA and the basal ganglia. Raven Press. [aNRS]Google Scholar

Baxter, L. R., Phelps, M. E., Maziotta, J. C., Schwartz, J. C., Gerner, R. H., Selin, G. E. & Sumida, R. M. (1985) Cerebral metabolic rates for glucose in mood disorders. Archives ofCeneral Psychiatry 42:441–47. [arNRS]CrossRefGoogle ScholarPubMed

Beart, P. M., Summers, R. J. & Christie, M. J. (1986) Mapping of excitatory amino acid projections to central gray and nucleus accumbens by D[³H]aspartate retrograde transport. In: Excitatory amino acid transmission, ed. Hicks, T., Lodge, D. & McLennan, H.. Plenum. [PMB]Google Scholar

Beckstead, R. M. (1979) An autoradiographic examination of corticocortical and subcortical projections of the mediodorsal-projection (prefrontal) cortex in the rat. Journal of Comparative Neurology 184:43–62. [GEJ, AEK]CrossRefGoogle ScholarPubMed

Beigel, A. & Murphy, D. L. (1971) Unipolar and bipolar affective illness: Differences in clinical characteristics accompanying depression. Archives of General Psychiatry 24:215–20. [AEK]CrossRefGoogle ScholarPubMed

Beninger, R. J. & Hahn, B. L. (1983) Pimozide blocks establishment but not expression of amphetamine-produced environment-specific conditioning. Sdence 220:1304–6. [PS]Google Scholar

Bennett, J. P., Enna, S. J., Bylund, D. B., Gillin, J. C., Wyatt, R. J. & Snyder, S. H. (1979) Neurotransmitter receptors in frontal cortex of schizophrenics. Archives of General Psychiatry 36:927–34. [aNRS]CrossRefGoogle ScholarPubMed

Bernardi, G., Cherubini, E., Marciani, G., Mercuri, N. & Stanzione, P. (1982) Responses of intracellularly recorded cortical neurons to the iontophoretic application of dopamine. Brain Research 245:267–74. [rNRS]CrossRefGoogle Scholar

Bird, E. D., Barnes, J., Iversen, L. L., Spokes, E. G., Mackay, A. V. P. & Shepherd, M. (1977) Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses. Lancet 2:1157–58. [aNRS]CrossRefGoogle ScholarPubMed

Bird, E. D., Crow, T. J., Iversen, L. L., Longden, A., Mackay, A. V. P., Riley, G. J. & Spokes, E. G. (1979) Dopamine and homovanillic acid concentrations in postmortem brain in schizophrenia. Journal of Physiology 293:36–37. [aNRS]Google ScholarPubMed

Bird, E. D., Spokes, E. G. & Iversen, L. L. (1979) Increased dopamine concentrations in limbic areas of brain from patients dying with schizophrenia. Brain 102:347–60. [aNRS, PMB]CrossRefGoogle ScholarPubMed

Blanc, G., Hervfi, D., Simon, H., Lisoprawski, A., Glowinski, J. & Tassin, P. (1980) Response to stress of meso-cortico-frontal DA neurons in rats after long-term isolation. Nature 284:265–67. [JPT]CrossRefGoogle Scholar

Bloom, F. E., Costa, F. & Salmoiraghi, G. (1965) Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. Journal of Pharmacology and Experimental Therapeutics 150:244–52. [JHF]Google ScholarPubMed

Bogerts, B., Meertz, E. & Schonfeldt-Bausch, R. (1985) Basal ganglia and limbic system pathology in schizophrenia. Archives of General Psychiatry 42:784–91. [JRS]CrossRefGoogle ScholarPubMed

Borsini, F., Pulvirenti, L. & Saminin, R. (1985) Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural “despair” test in rats. European Journal of Pharmacology 110:253–56. [PS]CrossRefGoogle ScholarPubMed

Bowers, M. B. Jr, (1974) Central dopamine turnover in schizophrenic syndromes. Archives of General Psychiatry 31:50–54. [aNRS]CrossRefGoogle ScholarPubMed

Bowers, M. B. Jr, & Hoffman, F. J. Jr, (1986) Homovanillic acid in caudate and prefrontal cortex following acute and chronic neuroleptic administration. Psychopharmacology 88:63–65. [GEJ]CrossRefGoogle ScholarPubMed

Braff, D. L., Stone, C., Callaway, E., Geyer, M., Click, I. & Bali, L. (1978) Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15:339–43. [arNRS]CrossRefGoogle ScholarPubMed

Braff, D. L., Swerdlow, N. R., Geyer, M., Mansbach, J. & Koob, G. (1986) Sensory gating deficits in rat acoustic startle: Effects of psychostimulants. Abstracts: American College of Neuropsychopharmacology. [rNRS]Google Scholar

Breier, A., Doran, A., Wolkowitz, O., Hommer, D. & Pickar, D. (1986) Negative and positive symptoms of schizophrenia: Pharmacologic and etiologic considerations. Presented at the Society of Biological Psychiatry, May 1986; Washington, D.C. [PS]Google Scholar

Bridge, S., Christie, M. J., & Beart, P. M. (1986) No change in neostriatal D-2 dopamine receptors after NMDA lesions of rat prefrontal cortex. Pharmacology, Biochemistry and Behaviour 24:1829–32. [PMB]CrossRefGoogle ScholarPubMed

Bridge, T. P., Kleinman, J. E., Soldo, B. J. & Karoum, F. (1987) Central catecholamines, cognitive impairment and affective state in elderly schizophrenics and controls. Biological Psychiatry 22:139–47. [rNRS]CrossRefGoogle ScholarPubMed

Bruyn, G. W. (1968) Huntington's chorea: Historical, clinical and laboratory synopsis. In: Handbook of clinical neurology, ed. Vinken, P. & Bruyn, G. W.. Elsevier. [aNRS]Google Scholar

Buchsbaum, M. S. & Rieder, R. O. (1979) Biologic heterogeneity and psychiatric research. Archives of General Psychiatry 36:1163–69. [AW]CrossRefGoogle Scholar

Bunney, B. S. & Grace, A. A. (1978) Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sciences 23:1715–28. [AAG]CrossRefGoogle ScholarPubMed

Bunney, W. E. Jr, & Davis, M. (1965) Norepinephrine in depressive reactions. Archives of General Psychiatry 13:483–94. [aNRS]CrossRefGoogle ScholarPubMed

Bunney, W. E. Jr, Post, R. M., Anderson, A. E. & Kopanda, R. T. (1977) A neuronal receptor sensitivity mechanism in affective illness (a review of evidence). Community Psychopharmacology 1:393–405. [aNRS]Google ScholarPubMed

Cancro, R. (1979) Genetic evidence for the existence of subgroups of the schizophrenic syndrome. Schizophrenic Bulletin 5:453–59. [AW]CrossRefGoogle ScholarPubMed

Carnoy, P., Ravard, S., Wemerman, B., Soubrie, P. & Simon, P. (1986) Behavioral deficits induced by low doses of apomorphine in rats: Evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs. Pharmacology Biochemistry and Behavior 25:503–9. [PS]CrossRefGoogle ScholarPubMed

Carlton, P. L. (1984) Analysis of physiological mechanism in psychopharmacology. Neuropsychobiology 12:158–72. [aNRS]Google ScholarPubMed

Carr, G. D. & White, N. M. (1983) Conditioned place preference from intraaccumbens but not intra-caudate amphetamine injections. Life Sciences 33:2551–57. [AEK]CrossRefGoogle Scholar

Carr, G. D. & White, N. M. (1986) Anatomical disassociation of amphetamine's rewarding and aversive effects: An intracranial microinjection study. Psychopharmacology 89:340–46. [AEK]CrossRefGoogle ScholarPubMed

Carter, C. J. (1980) Glutamergic pathways from the medial prefrontal cortex to the anterior striatum, nucleus accumbens and substantia nigra. British Journal of Pharmacology 70:50P–51P. [GEJ]Google Scholar

Cash, R., Dennis, T., L'Heureux, R., Raisman, R., Javoy-Agid, F. & Scatton, B. (1987) Parkinson's disease and dementia: Norepinephrine and dopamine in locus ceruleus. Neurology 37:42–46. [rNRS]CrossRefGoogle ScholarPubMed

Celesia, G. G. & Wanamaker, W. M. (1972) Psychiatric disturbances in Parkinson's diesase. Diseases of the Nervous System 33:577–83. [rNRS]Google Scholar

Charney, D. S., Menkes, D. B. & Heninger, G. R. (1981) Receptor sensitivity and the mechanism of action of antidepressant treatment. Archives of General Psychiatry 38:1160–80. [AEK]CrossRefGoogle ScholarPubMed

Chiodo, L. A. & Berger, T. W. (1986) Interactions between dopamine and amino acid induced excitation and inhibition in the striatum. Brain Research 375:198–203. [AAG]CrossRefGoogle ScholarPubMed

Chiodo, L. A. & Bunney, B. S. (1983) Typical and atypical neuroleptics: Differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. Journal of Neuroscience 3:160719. [AAG]CrossRefGoogle ScholarPubMed

Christie, M. J., Bridge, S., James, L. B. & Beart, P. M. (1985) Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Research 333:169–72. [PMB]CrossRefGoogle ScholarPubMed

Christie, M. J., James, L. B. & Beart, P. M. (1985) An excitant amino acid projection from the medial prefrontal cortex to the anterior part of the nucleus accumbens in the rat. Journal of Neurochemistry 45:477–82. [PMB]CrossRefGoogle Scholar

Christie, M. J., Rowe, P. J. & Beart, P. M. (1986) Effect of excitotoxin lesions in the medial prefrontal cortex on cortical and subcortical catecholamine turnover in the rat. Journal of Neurochemistry 47:1593–97. [PMB]CrossRefGoogle ScholarPubMed

Christie, M. J., Summers, R. J., Stephenson, J. A., Cook, C. J. & Beart, P. M. (in press) Excitatory amino acid projections in the rat brain. 1. Nucleus accumbens septi: A retrograde transport study utilizing D[³H]aspartate and [³H]GABA. Neuroscience. [PMB]Google Scholar

Chui, H. C., Mortimer, J. A., Slager, U., Zarow, C., Bondareff, W. & Webster, D. D. (1986) Pathological correlates of dementia in Parkinson's disease. Archives of Neurology 43:991–95. [AEK]CrossRefGoogle ScholarPubMed

Chute, D. L., Bank, B., Brooks, P. J., & Villiger, J. W. (1985) Intracellular biochemical events and mammalian behavior. Presented at the 4th World Congress of Biological Psychiatry, Philadelphia. [DLC]Google Scholar

Clayton, P., Pitts, F. N. Jr, & Winokur, G. (1965) Affective disorder: IV. Mania. Comparative Psychiatry 6:313–22. [AEK]CrossRefGoogle ScholarPubMed

Coffman, J. A., Andreasen, N. C. & Nasrallah, H. A. (1984) Left hemispheric density deficits in chronic schizophrenia Biological Psychiatry 19:1237–47. [AEK]Google ScholarPubMed

Cohen, D. H. (1986) Coming of age in neuroscience. Trends in Neurosciences 9:450–52. [MLM]CrossRefGoogle Scholar

Connor, J. D. (1970) Caudate nucleus neurons: Correlation of the effects of substantia nigra stimulation with iontophoretic dopamine. Journal of Physiology-London. 208:691–703. [rNRS]CrossRefGoogle ScholarPubMed

Cools, A. R. (1985a) Morphine and specific changes in the sensitivity of noradrenergic receptors within the “limbic” part of the feline caudate nucleus: A behavioural study. Brain Research Bulletin 14:239–50. [PMB]CrossRefGoogle Scholar

Cools, A. R. (1985b) Brain and behavior: Hierarchy of feedback systems and control of input. In: Perspectives in Ethology 6 (Mechanisms), ed. Bateson, P. P. G. & Klopfer, P. H.. Plenum. [ARC]Google Scholar

Cools, A. R., Jaspers, R., Schwartz, M. & Sontag, K. (1980) Basal ganglia and switching motor programs. In: The basal ganglia, ed. McKenzie, S., Kenin, R. & Wilcop, L.. Plenum. [aNRS]Google Scholar

Cools, A. R., Jaspers, R., Schwarz, M., Sontag, K. H., Vrijmoed-de Vries, M. & van den Bercken, J. (1984) Basal ganglia and switching motor programs. In: The basal ganglia, ed. McKenzie, J. S., Kemm, R. E. & Wilcock, L. N.. Plenum. [ARC]Google Scholar

Cools, A. R., van den Berken, J., Horstink, M., van Spaendonok, K. & Berger, H. (1984) Cognitive and motor shifting aptitude disorder in Parkinson's disease. Journal of Neurology, Neurosurgery and Psychiatry 47:443–53. [aNRS]CrossRefGoogle ScholarPubMed

Coppen, A. (1967) The biochemistry of affective disorders. British Journal of Psychiatry 113:1237–64. [aNRS]CrossRefGoogle ScholarPubMed

Costall, B., Domeney, A. M. & Naylor, R. J. (1982) Behavioral and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat. Neuropharmacology 21:327–35. [aNRS]CrossRefGoogle ScholarPubMed

Costall, B., Kelly, D. M. & Naylor, R. J. (1975) Nomifensine: A potent dopamine agonist of antiparkinson potential. Psychopharmacologia 4:153–64. [arNRS]CrossRefGoogle Scholar

Crawley, J. N., Stivers, J. A., Blumstein, L. K. & Paul, S. M. (1985) Cholecystokinin potentiates dopamine-mediated behaviors: Evidence for modulation specific to a site of coexistence. Journal of Neuroscience Research 5:1972–83. [rNRS]CrossRefGoogle ScholarPubMed

Creese, I., Burt, D. R. & Snyder, S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481–82. [aNRS, CEJ]CrossRefGoogle ScholarPubMed

Creese, I. & Iversen, S. D. (1975) The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Research 83:419–36. [aNRS]CrossRefGoogle ScholarPubMed

Creese, I. & Sibley, D. R. (1981) Receptor adaptations to centrally acting drugs. Annual Review of Pharmacology and Toxicology 21:357–89. [aNRS]CrossRefGoogle ScholarPubMed

Cross, A. J., Crow, T. J., Killpack, W. S., Longden, A., Owen, F. & Riley, G. J. (1978) The activity of brain dopamine-beta-hydroxylase and catechol-O-methyl-transferase in schizophrenics and controls. Psychopharmacology(Berlin) 59:117–21. [aNRS]CrossRefGoogle ScholarPubMed

Cross, A. J., Crow, T. J. & Owen, F. (1981) 3-H-flupenthixol binding in postmortem brains of schizophrenics: Evidence for a selective increase in dopamine D2 receptors. Psychopharmacology 74:122–24. [arNRS]CrossRefGoogle ScholarPubMed

Crow, T. J. (1980) Molecular pathology of schizophrenia: More than one disease process? British Medical Journal 280:66–68. [aNRS]CrossRefGoogle ScholarPubMed

Crow, T. J. (1982) Two syndromes in schizophrenia? Trends in Neurosciences 5:351–54. [AP]CrossRefGoogle Scholar

Crow, T. J., Corsellis, J. A. N., Cross, A. J., Frith, C. D., Johnstone, E. C., Owen, F., Bloxham, C. A., Ferrier, I. N. & Owens, D. G. C. (1981) The search for changes underlying the type II syndrome of schizophrenia. In: Biological psychiatry. Elsevier. [aNRS]Google Scholar

Crow, T. J., Cross, A. J., Johnson, J. A., Johnstone, E. C., Joseph, M. H., Owen, F., Owens, D. G. C. & Poutler, M. (1984) Catecholamines and schizophrenia: An assessment of the evidence. In: Catecholamines: Neuropharmacology and central nervous system-therapeutic aspects. Alan R. Liss. [aNRS]Google Scholar

Csernancky, J. C., Csernansky, C. A., Bonnet, K. A. & Hollister, L. E. (1985) Dopaminergic supersensitivity follows ferric chloride-induced limbic seizures. Biological Psychiatry 20:723–33. [aNRS]CrossRefGoogle Scholar

Csernansky, J. G., Csemansky, C. A., Glick, S. A. & Hollister, L. E. (1985) Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density. Psychopharmacology Bulletin 21:707–11. [aNRS]Google ScholarPubMed

D'Agata, R., Paci, C., Buongiorno, C, Gulizia, S., Marchetti, B., Gerendi, I., Posolo, P. & Rapisarda, V. (1979) Abnormal response of prolactin to TRH stimulus in depression. In: Neuroendocrine correlates in neurology and psychiatry. Elsevier/North Holland. [aNRS]Google Scholar

Danielezyk, W. (1983) Various mental behavioral disorders in Parkinson's disease, primary degenerative senile dementia and multiple infarction dementia. Journal of Neural Transmission 56:161–76. [rNRS]CrossRefGoogle Scholar

Davis, J. M. (1978) Dopamine theory of schizophrenia: A two-factor theory. In: The nature of schizophrenia. Wiley. [aNRS]Google Scholar

Davis, M. & Aghajanian, G. K. (1976) Effects of apomorphine and haloperidol on the acoustic startle response in rats. Psychopharmacology 47:217–223. [aNRS]CrossRefGoogle ScholarPubMed

Davis, M. & Kehne, J. (1985) Cocaine-excitatory effects of sensorimotor reactivity measured with acoustic startle. Psychopharmacology 86:31–36. [aNRS]CrossRefGoogle ScholarPubMed

DeFrance, J. F., Sikes, R. W. & Gottesfeld, Z. (1983) Regional distribution of catecholamines in nucleus accumbens of the rabbit. Journal of Neuwchcmistry 40:291–93. [rNRS, PMB]CrossRefGoogle ScholarPubMed

Dement, W., Zarcone, V., Ferguson, J., Cohen, H., Pivin, T. & Barchas, J. (1968) Some parallel findings in schizophrenic patients and serotonindepleted cats. Psychophysiology 5:239–51. [aNRS]Google Scholar

De Olmos, J. S., Alheid, G. F. & Beltramino, C. A. (1985) The amygdala. In: The rat nervous system, vol. 1: Forebrain and midbrain, ed. Paxinos, G.. Academic Press. [GFA]Google Scholar

Depue, R. A. & Monroe, S. M. (1978) The unipolar-bipolar distinction in the depressive disorders. Psychological Bulletin 85:1001–29. [AEK]CrossRefGoogle ScholarPubMed

Detre, T., Himmelhoch, J., Swartzburg, M., Anderson, C. M., Byck, R. & Kupfer, D. J. (1972) Hypersomnia and manic-depressive disease. American Journal of Psychiatry 128:1303–5. [AEK]CrossRefGoogle ScholarPubMed

deWit, H. & Wise, R. A. (1978) Blockade of cocaine reinforcement in rats with the dopamine receptor blocker pimozide, but not with the noradrenergic blockers phentolamine and phenoxybenzamine. Canadian Journal of Psychology 31:195–203. [aNRS]CrossRefGoogle Scholar

Divac, I., Bjorklund, A., Lindvall, O. & Passingham, R. E. (1978) Converging projections from the medio-dorsal nucleus and mesencephalic dopaminergic neurons to the neocortex in three species. Journal of Comparative Neurology 180:59–72. [GE], JPT]CrossRefGoogle Scholar

Downs, N. S., Britton, K. T., Gibbs, D. M., Koob, G. F. & Swerdlow, N. R. (1986) Supersensitive endocrine response to physostigmine in dopamine depleted rats: A model of depression. Biological Psychiatry 21:773. [arNRS]CrossRefGoogle ScholarPubMed

Dray, A. & Oakley, N. R. (1978) Projections from nucleus accumbens to globus pallidus and substantia nigra in the rat. Experientia 34:68–70 [rNRS]CrossRefGoogle ScholarPubMed

Ehlers, C. L., Indik, J. H., Koob, G. F. & Bloom, F. E. (1983) The effect of a single and repeated electroconvulsive shock (ECS) on locomotor activity in rats. Progress in Neuropsychopharmacology and Biological Psychiatry 7:217–22. [aNRS]CrossRefGoogle ScholarPubMed

Ehlers, C. L. & Koob, G. F. (1985) Locomotor behavior following kindling in three different brain sites. Brain Research 326:71–79. [aNRs]CrossRefGoogle ScholarPubMed

Emson, P. C. & Koob, G. F. (1978) The origin and distribution of dopamine containing afferents to the rat frontal cortex. Brain Research 142:249–67. [aNRS]CrossRefGoogle Scholar

Endo, K., Araki, T. & Yagi, N. (1973) The distribution and pattern of axon branching of pyramidal tract cells. Brain Research 57:484–91. [aNRS]CrossRefGoogle ScholarPubMed

Fallon, J. H., Hicks, R. & Loughlin, S. E. (1983) The origin of cholecystokinin terminals in the basal forebrain of the rat: Evidence from immunofluorescence and retrograde tracing. Neuroscience Letters 37:29–35. [JHF]CrossRefGoogle ScholarPubMed

Fallon, J. H. & Loughlin, S. E. (in press) Monoamines in the cerebral cortex and a theory on the functions of monoamines in cortex and basal ganglia. In: Cerebral cortex, vol. 6, ed. Jones, E. G. & Peters, A.. [JHF]Google Scholar

Fallon, J. H., Loughlin, S. E. & Ribak, C. E. (1983) The islands of Calleja complex of rat basal forebrain. III. Histochemical evidence for a striatopallidal system. Journal of Comparative Neuroscience 16:19–120. [JHF]Google Scholar

Farkas, T.Wolf, A. P., Jaeger, J., Brodie, J. D., Christman, D. R. & Fowler, J. S. (1984) Regional brain glucose metabolism in chronic schizophrenia. Archives of General Psychiatry 41:293–300. [AW]CrossRefGoogle ScholarPubMed

Farley, I. J., Price, K. S., McCullough, E., Deck, J. H. N., Hordynski, W. & Hornykiewicz, O. (1978) Norepinephrine in chronic paranoid schizophrenia: Above-normal levels in limbic forebrain. Science 200:456–58. [PMB]CrossRefGoogle ScholarPubMed

Feltz, P. & Albe-Fessard, D. (1972) A study of an ascending nigrocaudate pathway. Electroencephalography and Clinical Neurophysiology-EEG Journal 33:179–93. [JHF]CrossRefGoogle ScholarPubMed

Fibiger, H. C. (1984) The neurobiological substrates of depression in Parkinson's disease: A hypothesis. Canadian Journal of Neurological Sciences 11:105–7. [HCF]CrossRefGoogle ScholarPubMed

Fibiger, H. C., Carter, D. A. & Phillips, A. G. (1976) Decreased intracranial self-stimulation after neuroleptics or 6-hydroxydopamine: Evidence for mediation by motor deficits rather than by reduced reward. Psychopharmacology 47:21–27. [aNRW]CrossRefGoogle ScholarPubMed

Fibiger, H. C. & Lloyd, K. G. (1984) The neurobiological substrates of tardive dyskinesia: The GABA hypothesis. Trends in Neuroscience 7:462–64. [HCF]CrossRefGoogle Scholar

Fibiger, H. C. & Phillips, A. G. (1986) Reward, motivation and cognition: Psychobiology of meso-telencephalic dopamine systems. In: Handbook of physiology: The nervous system. Vol. 4: Intrinsic regulatory systems of the brain, ed. Bloom, F. E. & Geiger, S. R.. American Physiological Society. [HCF]Google Scholar

Fibiger, H. C. & Phillips, A. G.(1987) Role of catecholamine transmitters in brain reward systems:Implications for the neurobiology of affect. In: Brain reward systems and abuse, ed. Engel, J. & Oreland, L.. Raven Press. [HCF]Google Scholar

Flowers, K. A. & Robertson, C. (1985) The effect of Parkinson's disease on the ability to maintain a mental set. Journal of Neurology, Neurosurgery and Psychiatry 48:517–29. [aNRS]CrossRefGoogle ScholarPubMed

Fonnum, F., Storm-Mathisen, J. & Divac, I. (1981) Biochemical evidence for glutamate as neurotransmitter in corticostriatal and corticothalamic fibres in rat brain. Neuroscience 6:863–73. [aNRS]CrossRefGoogle ScholarPubMed

Fouriezos, G.Hansson, P. A. & Wise, R. A. (1978) Decreased intracranial self-stimulation after neuroleptics: Mediation by reduced reward, not performance debilitation. Journal of Comparative Physiology and Psychology 92:659–69. [aNRS]Google Scholar

Franks, R. D., Alder, L. E., Waldo, M. C., Alport, J. & Freedman, R. (1983) Neurophysiological studies of sensory gating in mania: Comparison with schizophrenia. Biological Psychiatry 18:989–1005. [AEK]Google ScholarPubMed

Franzen, G. & Ingvar, D. H. (1975) Abnormal distribution of cerebral activity in chronic schizophrenia. Journal of Psychiatric Research 12:199–214. [aNRS]CrossRefGoogle ScholarPubMed

Friedhoff, A. J. (1986) A dopamine dependent restitutive system for the maintenance of mental normalcy. Annals of the New York Academy of Sciences 463:47–52. [rNRS]CrossRefGoogle ScholarPubMed

Friedhoff, A. J. & Van Winkle, E. (1962) Isolation and characterization of a compound from the urine of schizophrenics. Nature 194:897–99. [aNRS]CrossRefGoogle Scholar

Galey, D., Durkin, T., Sitakis, G., Kempf, E. & Jaffard, R. (1985) Facilitation of spontaneous and learned spatial behaviours following 6- hydroxydopamine lesions of the lateral septum: A cholinergic hypothesis. Brain Research 340:171–74. [JAG]CrossRefGoogle ScholarPubMed

Gallagher, D. W., Pert, A. & Bunney, W. E. (1978) Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 273:309–12. [aNRS]CrossRefGoogle Scholar

Gardner, E. L., Hirshhorn, I., Seeger, T. F., Weiss, M. & Makman, M. H. (1980) Comparative effects of lithium on drug-induced and lesion-induced dopaminergic supersensitivity. Society of Neuroscience Abstracts 6:546. [aNRS]Google Scholar

Gelissen, M. & Cools, A. (1986) The interrelationship between superior colliculus and substantia nigra pars reticulata in programming movements of cats. Behavioural Brain Research 21:85–93. [ARC]CrossRefGoogle ScholarPubMed

Gerfen, C. R. (1984) The neostriatal mosaic: Cornpartmentalization of corticostriatal input and striatonigral output systems. Nature 311:461–64. [aNRS]CrossRefGoogle ScholarPubMed

Ginton, A., Urea, G. & Lubow, R. E. (1975) The effects of preexposure to a non-attended stimulus on subsequent learning: Latent inhibition in adults. Bulletin of the Psychonomic Society 5:5–8. [JAG]CrossRefGoogle Scholar

Glowinski, J., Tassin, J. P. & Thierry, A. M. (1984) The mesocorticoprefrontal dopaminergic neurons. Trends in Neuroscience 7:415–18. [GEJ, JPT]CrossRefGoogle Scholar

Gold, L. H., Swerdlow, N. R. & Koob, G. F. (1986) Mesolimbic dopamine lesions block the unconditioned and conditioned motor effects of amphetamine. Neuroscience Abstracts 12:1137. [rNRS]Google Scholar

Golden, C. J., Graber, B., Coffman, J., Berg, R. A., Newlin, D. B. & Bloch, S. (1981) Structural brain deficits in schizophrenia. Archives of General Psychiatry. 38:1014–17. [AEK]CrossRefGoogle ScholarPubMed

Goldman, P. S. & Nauta, W. J. H. (1977) An intricately patterned prefrontalcaudate projection in the rhesus monkey. Journal of Comparative Neurology 171:369–86. [AEK]CrossRefGoogle Scholar

Goodwin, F. K. & Bunney, W. E. Jr, (1973) A psychobiological approach to affective illness. Psychiatric Annals 3:19–53. [aNRS]CrossRefGoogle Scholar

Goodwin, F. K., Murphy, D. L., Brodie, H. K. H. & Bunney, W. E. (1970) L-Dopa, catecholamines, and behavior: A clinical and biochemical study in depressed patients. Biological Psychiatry 2:341–66. [aNRS]Google ScholarPubMed

Grace, A. A. (1983) Nigral dopamine neurons: Identification, characterization, and effects of autoreceptor stimulation. Ph.D. dissertation, Yale University. [AAG]Google Scholar

Grace, A. A. & Bunney, B. S. (1985) Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity. Brain Research 333:271–84. [AAG]CrossRefGoogle ScholarPubMed

Grace, A. A. & Bunney, B. S. (1986) Induction of depolarization block in midbrain dopamine neurons by repeated administration of haloperidol: Analysis using in vivo intracellular recording. Journal of Pharmacology and Experimental Therapeutics 238:1092–1100. [AAG]Google ScholarPubMed

Gray, J. A. (1972) The structure of the emotions and the limbic system. In: Physiology, emotion and psychosomatic illness, ed. Porter, R. & Knight, J.. Amsterdam: Association of Scientific Publishers. [JAG]Google Scholar

Gray, J. A. (1975) Elements of a two-process theory of learning. Academic Press. [JAG]Google Scholar

Gray, J. A. (1982a) The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. Oxford University Press. [JAG]Google Scholar

Gray, J. A. (1982b) Préicis of The neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system. Behavioral and Brain Sciences 5:469–84. [JAG]CrossRefGoogle Scholar

Gray, J. A. (1985) Issues in the neuropsychology of anxiety. In: Anxiety and the anxiety disorders, ed. Tuma, A. H. & Maser, J. D.. Erlbaum. [JAG]Google Scholar

Gray, J. A. (1987) The psychology of fear and stress, 2nd ed.Cambridge University Press. [JAG]Google Scholar

Gray, J. A. (in press) The neuropsychology of emotion and personality. In: Proceedings of symposium on cognitive neurochemistry, Harlow, Essex, 1986, ed. Iversen, S. D. & Stahl, S. M.. Oxford University Press. [JAC]Google Scholar

Gray, J. A. & Smith, P. T. (1969) An arousal-decision model for partial reinforcement and discrimination learning. In: Animal discrimination learning, ed. Gilbert, R. & Sutherland, N. S.. Academic Press. [JAG]Google Scholar

Green, A. R., Heal, D. J. & Grahame-Smith, D. G. (1977) Further observations on the effect of repeated electroconvulsive shock on the behavioral responses of rats produced by increase in the functional activity of brain 5-hydroxytryptamine and dopamine. Psychopharmacology 52:195–200. [aNRS]CrossRefGoogle ScholarPubMed

Gregoire, F., Brauman, H., Debuck, R. & Corvilain, J. (1977) Hormone release in depressed patients, before and after recovery. Psychoneuroendocrinology 2:303–11. [aNRS]CrossRefGoogle ScholarPubMed

Groenewegen, H. J. & Russchen, F. T. (1984) Organization of the efferent projections of the immunohistochemical study in the cat. Journal of Comparative Neurology 223:347–67. [GFA]CrossRefGoogle ScholarPubMed

Grof, E., Brown, G. M. & Grof, P. (1983) Neuroendocrine strategies in affective disorders. Progress in Seuropsychopharmacology and Biological Psychology 7:557–82. [aNRS]Google ScholarPubMed

Groves, P. M. (1983) A theory of the functional organization of the neostriatum and the neostriatal control of voluntary movement. Brain Research Reviews 5:109–32. [aNRS, JHF, ELG, AAG]CrossRefGoogle Scholar

Growden, J. H. (1982) Medical treatment of extrapyramidal diseases. In: Update III: Harrison's principles of internal medicine, ed. lsselbacher, K. J.. McGraw-Hill. [aNRS]Google Scholar

Gruenthal, M. (1980) The effect of lithium administration on apomorphineinduced rotation following unilateral destruction of the nigrostriatal pathway in the rat. Society of Neurosdence Abstracts 6:546. [aNRS]Google Scholar

Gruzelier, J. H. & Venables, P. H. (1972) Skin conductance orienting activity in a heterogeneous sample of schizophrenics. Journal of Nervous and Mental Disease 155:277–87. [rNRS]CrossRefGoogle Scholar

Cunne, L. M., Anggard, E. & Jonsson, L. E. (1972) Clinical trials with amphetamine-blocking drugs. Psychiatric Neurology and Neurobiology 75:225–26. [aNRS]Google Scholar

Haber, S. N. & Watson, S. J. (1985) The comparative distribution of enkephalin, dynorphin and substance P in the human globus pallidus and basal forebrain Neurosdence 14:1011–24. [aNRS]CrossRefGoogle ScholarPubMed

Halaris, A., Belendiuk, K. & Freedom, D. (1975) Antidepressant drugs affect brain dopamine. Biochemical Pharmacology 24:1896–98. [arNRS]CrossRefGoogle Scholar

Hall, M. D., Jenner, P., Kelly, E. & Marsden, C. D. (1983) Differential anatomical location of [³H]-N,n-propylnorapomorphine and [³H] spiperone binding sites in the striatum and substantia nigra of the rat. British Journal of Pharmacology 79:599–610. [PMB]CrossRefGoogle Scholar

Heath, R. G. (1962) Common characteristics of epilepsy and schizophrenia: Clinical observation and depth electrode studies. American Journal of Psychiatry 118:1013–26. [aNRS]CrossRefGoogle ScholarPubMed

Heimer, L., Alheid, G. F., & Zaborszky, L. (1985) Basal ganglia. In: The rat nervous system, vol. 1: Forebrain and midbrain, ed. Paxinos, G.. Academic Press. [GFA]Google Scholar

Heimer, L., Switzer, R. D. & Van Hoesen, G. W. (1982) Ventral striatum and ventral pallidum: Components of the motor system?. Trends in Neurosdence 5:83–87. [aNRS]CrossRefGoogle Scholar

Heimer, L. & Wilson, R. D. (1975) The subcortical projections of the allocortex: Similarities in the neural associations of the hippocampus, the piriform cortex, and the neocortex. In: Colgi centennial symposium proceedings, ed. Santini, M.. Raven Press. [aNRS]Google Scholar

Herman, J. P., Guilloneau, D., Dantzer, R., Scatton, B., Semerdjian-Rouquier, L. & Le Moal, M. (1982) Differential effects of inescapable footshocks and of stimuli previously paired with inescapable footshock on dopamine turnover in cortical and limbic areas of the rat. Life Sdences 30:2207–14. [GEJ]CrossRefGoogle ScholarPubMed

Herrling, P. L. & Hull, C. D. (1984) Iontophoretically applied dopamine depolarizes and hyperpolarizes the membrane of cat caudate neurons Brain Research 192:441–62. [rNRS]CrossRefGoogle Scholar

Hersh, S. M. & White, E. L. (1981) Thalamocortical synapses with corticothalamic projection neurons in mouse sml cortex: Electron microscopic demonstration of a monosynaptic feedback loop. Neurosdence Letters 24:207–10. [aNRS]CrossRefGoogle Scholar

Herve, D., Studler, J. M., Blanc, G., Glowinski, J., Holcomb, H. H., Sternberg, A. E. & Heninger, G. R. (1983) Effects of electroconvulsive therapy on mood, parkinsonism and tardive dyskinesia in a depressed patient: ECT and dopamine systems. Biological Psychiatry 18:865–73. [rNRS]Google Scholar

Herve, D., Studler, J. M., Blanc, G., Glowinski, J., & Tassin, J. (1986) Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation. Brain Research 383:47–53. [rNRS]CrossRefGoogle ScholarPubMed

Hoebel, B. G., Monaco, A. P., Hernandez, L., Aulisi, E. F., Stanley, B. G. & Lenard, L. (1983) Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158–63. [AEK]CrossRefGoogle ScholarPubMed

Hokfelt, T., Eferitt, B. J., Theodorsson-Norheim, E. & Goldstein, M. (1984) Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic, and medullary catecholamine neurons. Journal of Comparative Neurology 222:543–59. [PWK]CrossRefGoogle Scholar

Hokfelt, T., Skirboll, L., Rehfeld, J., Goldstein, M., Markey, M. & Dann, O. (1980) A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: Evidence from immunocytochemistry combined with retrograde tracing. Neurosdence 5:2093–2124. [JHF]CrossRefGoogle ScholarPubMed

Holcomb, H. H.Stemberg, A. E. & Heninger, G. R. (1983) Effects of electroconvulsive therapy on mood, parkinsonism and tardive dyskinesia in a depressed patient: ECT and dopamine systems. Biological Psychiatry 18:865–73. [arNRS]Google Scholar

Hollister, L. E. (1978) Psychiatric disorders. In: Clinical pharmacology: Basic prindples in therapeutics, ed. Melmon, K. L. & Morelli, H. F.. MacMillan. [aNRS]Google Scholar

Hommer, D. W., Pickar, D., Roy, A., Ninan, P., Boronow, J. & Paul, S. (1984) The effects of ceruletide in schizophrenia. Archives of General Psychiatry 41:617–19. [rNRS]CrossRefGoogle ScholarPubMed

Horn, A. S., & Snyder, S. H. (1971) Chlorpromazine and dopamine: Conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proceedings of the National Academy of Sdence, [JRS]CrossRefGoogle Scholar

Hornykiewicz, O. (1963) Die topische localisation das verhalten von noradrenalin und dopamin (3-hydroxytyramin) in der substantia nigra des normalen und Parkinson-kranken menschen. Wiener Klinische Wochenschrift 57:309–12. [aNRS]Google Scholar

Hornykiewicz, O. (1982) Brain catecholamines in schizophrenia - a good case for noradrenaline. Nature 299:484–86. [PMB]CrossRefGoogle ScholarPubMed

Ingvar, D. H. & Franzen, G. (1974) Distribution of cerebral activity in chronic schizophrenia. Lancet 2:1481–85. [aNRS]Google ScholarPubMed

Jacobs, B. L., Trulson, M. E. & Stem, W. C. (1977) Behavioral effects of LSD in the cat: Proposal of an animal behavior model for studying the actions of hallucinogenic drugs. Brain Research 132:301–14. [aNRS]CrossRefGoogle ScholarPubMed

Jaeckle, R. S. & Nasrallah, H. A. (1985) Major depression and carbon monoxide-induced parkinsonism: Diagnosis, computerized axial tomography, and response to L-dopa. Journal of Nervous and Mental Disorders 173:503–8. [aNRS]CrossRefGoogle ScholarPubMed

Janowsky, D. S., Davis, J. M., El-Yousef, M. K. & Sekerke, H. J. (1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1:632–35. [aNRS]CrossRefGoogle Scholar

Jaspers, R., Schwarz, M., Sontag, K.-H. & Cools, A. (1984) Caudate nucleus and programming behaviour in cats: Role of dopamine in switching motor patterns. Behavioural Brain Research 14:17–28. [ARC]CrossRefGoogle ScholarPubMed

Javoy-Agid, F. & Agid, Y. (1980) Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 30:1326–30. [aNRS]CrossRefGoogle Scholar

Jimerson, D. C. & Post, R. M. (1984) Psychomotor stimulants and dopamine agonists in depression. In: Neurobiology of mood disorders, ed. Post, R. M. & Ballenger, J. C.. Williams and Wilkins. [arNRS]Google Scholar

Jones, D. L. & Mogenson, G. J. (1980a) Nucleus accumbens to globus pallidus GABA projection: Electrophysiological and iontophoretic investigations. Brain Research 188:93–105. [arNRS]CrossRefGoogle ScholarPubMed

Jones, D. L. & Mogenson, G. J. (1980b) Nucleus accumbens to globus pallidus GABA projection subserving ambulatory activity. American Journal of Physiology 238:R63–69. [rNRS]Google ScholarPubMed

Jones, E. G. & Powell, T. P. S. (1970) An anatomical study of converging sensory pathways within the cerebral cortex of the monkey. Brain 93:793–820. [aNRS][CrossRefGoogle ScholarPubMed

John, E. R. (1986) Personal communication. [AW]Google Scholar

Joyce, E. M., Koob, G. F., Strecker, R., Iversen, S. D. & Bloom, F. E. (1981) The behavioral effects of enkephalin analogues injected into the ventral tegmental area and globus pallidus. Brain Research 221:359–70. [PWK]CrossRefGoogle ScholarPubMed

Judd, L. L., Risch, S. C., Parker, D. C., Janowsky, D., Segal, A. & Huey, L. (1982) Prolactin and growth hormone blunted in depression. New Research Abstracts of the APA Annual Meeting, Toronto. [aNRS]Google Scholar

Juhl, R. P., Tsuang, M. T. & Perry, P. J. (1977) Concomitant administration of haloperidol and lithium carbonate in acute mania. Diseases of the Nervous System 38:675. [aNRS]Google ScholarPubMed

Kalivas, P. W. (1985) Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neuroscience and Biobehavioral Reviews 9:573–87. [PWK]CrossRefGoogle ScholarPubMed

Kalivas, P. W., Nemeroff, C. B. & Prange, A. J. Jr, (1984) Neurotensin microinjection into the nucleus accumbens antagonizes dopamineinduced increase in locomotion and rearing. Neuroscience 1:919–30. [PWK]CrossRefGoogle Scholar

Kehne, J. H. & Sorenson, C. A. (1978) The effects of pimozide and phenoxybenzamine pretreatment on amphetamine and apomorphine potentiation of the acoustic startle response in rats. Psychopharmacology 58:137–44. [aNRS]CrossRefGoogle ScholarPubMed

Kelley, A. E. & Domesick, V. B. (1982) The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: An anterograde- and retrograde-horseradish peroxidase study. Neuroscience 7:2321–35. [aNRS, JAG]CrossRefGoogle Scholar

Kelley, A. E., Domesick, V. B. & Nauta, W. J. H. (1982) The amygdalostriatal projection in the rat – an anatomical study by anterograde and retrograde tracing methods. Neuroscience 7:615–30. [aNRS, AEK]CrossRefGoogle ScholarPubMed

Kelley, A. E. & Stinus, L. (1985) Disappearance of hoarding behavior after 6-hydroxydopamine lesions of the mesolimbic dopamine neurons and its reinstatement with L-dopa. Behavioral Neuroscience 99:531–45. [arNRS, AEK]CrossRefGoogle ScholarPubMed

Kelley, A. E., Stinus, L. & Iversen, S. D. (1980) Interactions between D-alamet-enkephalin, A10 dopaminergic neurones, and spontaneous behavior in the rat. Behavioral Brain Research 1:3–24. [aNRS]CrossRefGoogle ScholarPubMed

Kelly, P. H. & Iversen, S. D. (1976) Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats. European Journal of Pharmacology 40:45–56. [aNRS]CrossRefGoogle Scholar

Kelly, P. H.Seviour, P. W., & Iversen, S. P. (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens, septi, and corpus striatum. Brain Research 94:507–22. [aNRS, AEK]CrossRefGoogle ScholarPubMed

Kety, S. S. (1970) Current biochemical research in schizophrenia. In: Psychopathology of schizophrenia, ed. Hoch, P. A. & Zubin, J.. Basic Books. [aNRS]Google Scholar

Kilpatrick, I.C., Collingridge, C. & Starr, M. (1982) Evidence for the participation of nigrotectal gammaaminobutyrate containing neurons in striatal and nigral-derived circling in the rat. Neuroscience 7:207–22. [AAC]CrossRefGoogle ScholarPubMed

Kim, J. S., Hassler, R., Haug, P. & Paik, K. S. (1977) Effect of frontal cortex ablation on striatal glutamic acid level in rat. Brain Research 132:370–74. [aNRS]CrossRefGoogle ScholarPubMed

Kim, J. S. & Kornhuber, H. H. (1982) The glutamate theory in schizophrenia: Clinical and experimental evidence. In: Psychobiology of schizophrenia, ed. Namba, M. & Kaiya, H.. Pergamon. [PMB]Google Scholar

King, R. (1985) Motivational diversity and mesolimbic dopamine: An hypothesis concerning temperament. In: Emotion: Theory, research and experience, vol. 3, Biological foundations of emotion, ed. Plutchick, R.. Academic Press. [arNRS]Google Scholar

King, R. J., Mefford, I. N., Wang, C., Murchison, A., Caligari, E. J. & Berger, P. A. (1986) CSF dopamine levels correlate with extroversion in depressed patients. Psychological Research 19:305–10. [rNRS]Google ScholarPubMed

Kita, H., Kita, T. & Kitai, S. T. (1985) Regenerative potentials in rat neostriatal neurons in an in vitro slice preparation. Experimental Brain Research 60:63–70. [AAG]Google Scholar

Kitai, S. T., Iuginiori, M. & Kocsis, J. D. (1976) Excitatory nature of dopamine in the nigro-caudate pathway. Experimental Brain Research 24:351–63. [JHF]CrossRefGoogle ScholarPubMed

Kitai, S. T., Sugimori, M. & Kocsis, J. D. (1976) Excitatory nature of dopamine in the nigro-caudate pathway. Experimental Brain Research 24:351–63. [rNRS]CrossRefGoogle ScholarPubMed

Kleinman, J. E. (1986) Postmortem neurochemistry studies in schizophrenia. In: The neurology of schizophrenia, ed. Nasrallah, H. & Weinberger, D. R.. Elsevier. [GEJ]Google Scholar

Klerman, G. L. & Cole, J. O. (1965) Clinical pharmacology of imipramine and related antidepressant compounds. Pharmacology Review 17:101–41. [aNRS]Google ScholarPubMed

Knapp, S., Mandell, A. J. & Geyer, M. A. (1974) Effects of amphetamine on regional tryptophan hydroxylase activity and synaptosomal conversion of tryptophan to 5-hydroxytryptamine in rat brain. Journal of Pharmacology and Experimental Therapy 189:676–89. [aNRS]Google ScholarPubMed

Koda, L. Y. & Gibb, J. W. (1971) The effect of repeated large doses of methamphetamine on adrenal and brain tyrosine hydroxylase. Pharmacologist 13:253. [aNRS]Google Scholar

Kolb, B. & Whishaw, I. Q. (1983) Performance of schizophrenic patients on tests sensitive to left or right frontal, temporal, or parietal function in neurologic patients. Journal of Nervous and Mental Disease 171:435–43. [BK]CrossRefGoogle ScholarPubMed

Koob, G. F., Balcom, G. J. & Meyerhoff, J. L. (1976) Increases in intracranial self-stimulation in the posterior hypothalamus following unilateral lesions in the locus coeruleus. Brain Research 101:554–60. [rNRS]CrossRefGoogle ScholarPubMed

Koob, G. F., Riley, S. J., Smith, S. C. & Robbins, T. W. (1978) Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity and amphetamine anorexia in the rat. Journal of Comparative and Physiological Psychology 92:917–27. [AEK]CrossRefGoogle ScholarPubMed

Kornetsky, C. (1976) Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine. Archives of General Psychiatry 33:1425–28. [aNRS]CrossRefGoogle ScholarPubMed

Kornetsky, C. & Esposito, R. U. (1979) Euphorigenic drugs: Effects on reward pathways of the brain. Federal Proceedings 38:2473–76. [aNRS]Google ScholarPubMed

Kozlowski, M. R., Neve, K. A., Grishman, J. E. & Marshall, J. F. (1983) Chronic lithium administration alters behavioral recovery from nigrostriatal injury: Effects on neostriatal (3H) spiroperidol binding sites. Brain Research 267:301–11. [aNRS]CrossRefGoogle ScholarPubMed

Kupfer, D. J., Himmelhoch, J. M., Swartzburg, M., Anderson, C., Byck, R. & Detre, P. (1972) Hypersomnia in manic depressive disease. Disorders of the Nervous System 33:720–24. [AEK]Google ScholarPubMed

Lavielle, S., Tassin, J. P., Thierry, A. M., Blanc, G., Hervé, D., Barthélémy, C. & Glowinski, J. (1979) Blockade by benzodiazepines of the selective high increase in DA turnover induced by stress in mesocortical DA neurons of the rat. Brain Research 168:585–94. [JPT]CrossRefGoogle ScholarPubMed

Le Dourarin, C., Oblin, A., Fage, D. & Scatton, B. (1983) Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment. European Journal of Pharmacology 93:55–62. [aNRS]CrossRefGoogle Scholar

Lee, T. & Seeman, P. (1977) Dopamine receptors in normal and schizophrenic human brains. Society of Neuroscience Abstracts 3:443. [arNRS]Google Scholar

Lee, T., Seeman, P., Tourellotte, W. W., Farley, I. J. & Hornykeiwicz, O. (1978) Binding of 3-H-neuroleptics and 3-H-apomorphine in schizophrenic brains. Nature 274:897–900. [arNRS]CrossRefGoogle Scholar

Leith, N. J. & Barrett, R. J. (1980) Effects of chronic amphetamine or reserpine on self-stimulation responding: Animal model of depression? Psychopharmacology 72:9–15. [aNRS]CrossRefGoogle ScholarPubMed

Le Moal, M., Cardo, B. & Stinus, L. (1969) Influence of ventral mesencephalic lesions on various spontaneous and conditional behaviours in the rat. Physiology b Behaviour 4:567–74. [JPT]CrossRefGoogle Scholar

Leonard, C. M. (1969) The prefrontal cortex of the rat. Brain Research 12:321–43. [GEJ]CrossRefGoogle ScholarPubMed

Levin, S. (1984a) Frontal lobe dysfunctions in schizophrenia: I. Eye movement impairments. Journal of Psychiatric Research 18:27–55. [arNRS]CrossRefGoogle ScholarPubMed

Levin, S. (1984b) Frontal lobe dysfunction in schizophrenia II: Impairments of psychological brain functions. Journal of Psychiatric Research 18:57–72. [AEK]CrossRefGoogle ScholarPubMed

Llinas, R. & Yarom, Y. (1981) Properties and distribution of ionic conductances generating electroresponsiveness of mammalian inferior olivary neurones in vitro. Journal of Physiology (London) 315:569–84. [AAG]CrossRefGoogle ScholarPubMed

Loranger, A. W. (1981) Genetic independence of manic-depression and schizophrenia. Acta Psychiatrica Scandinavica 63:444–52. [AEK]CrossRefGoogle ScholarPubMed

Lotstra, F., Verbanck, P., Mendlewicz, J. & Vanderhaeghen, J. (1984) No evidence of antipsychotic effect of caerulein in schizophrenic patients free of neuroleptics – a double-blind crossover study. Biological Psychiatry 19:877–82. [rNRS]Google Scholar

Louilot, A., Simon, H., Taghzouti, K. & Le Moal, M. (1985) Modulation of dopaminergic activity in the nucleus accumbens following facilitation or blockade of the dopaminergic transmission in the amygdala: A study by in vivo differential pulse voltammetry. Brain Research 346:141–45. [JPT]CrossRefGoogle ScholarPubMed

Lubow, R. E. (1973) Latent inhibition. Psychological Bulletin 79:398–407. [JAG]CrossRefGoogle ScholarPubMed

Lyon, M & Robbins, T. (1975) The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects. In: Current developments in psychopharmacology. Vol. 2. Spectrum. [aNRS]Google Scholar

Mackay, A. V. P. (1982) Increased brain dopamine and dopamine receptors in schizophrenia. Archives of General Psychiatry 39:991–97. [arNRS]CrossRefGoogle ScholarPubMed

Maier, S. F. & Seligman, M. E. P. (1976) Learned helplessness: Theory and evidence. Journal of Experimental Psychology: General 105:3–46. [aNRS]CrossRefGoogle Scholar

Major, L., Murphy, D. L. & Lipper, S. (1979) Effects of clorgyline and pargyline on deaminated metabolites of norepinephrine, dopamine and serotonin in human cerebrospinal fluid. Journal of Neurochemistry 32:229–31. [aNRS]CrossRefGoogle ScholarPubMed

Man in ‘T’ Veld, A. J., Boomsma, F., Moleman, P. & Schalekamp, M. A. D. H. (1987) Congenital dopamine-beta-hydroxylase deficiency: A novel orthostatic syndrome. Lancet 1:183–87. [rNRS]CrossRefGoogle Scholar

Marsden, C. D. (1980) The enigma of the basal ganglia and movement. Trends in Neurosciences 3:284–87. [GFA]CrossRefGoogle Scholar

Marsden, C. D. (1984) Which motor disorder in Parkinson's disease indicates the true motor function of the basal ganglia? In: Functions of the basal ganglia, ed. Evarts, E.. Ciba Foundation Symposium 107. [aNRS, AAG]Google ScholarPubMed

Martin-Iverson, M. T., Leclere, J. F. & Fibiger, H. C. (1983) Cholinergicdopaminergic interactions and the mechanisms of action of antidepressants. European Journal of Pharmacology 94:193–201. [aNRS]CrossRefGoogle ScholarPubMed

Mattes, J. A., Horn, W., Rochford, J. M. & Orlosky, M. (1985) Ceruletide for schizophrenia: A double-blind study. Biological Psychiatry 20:533–38. [rNRS]CrossRefGoogle ScholarPubMed

Mattes, J. A. & Rochford, J. M. (1985) A high dose double-blind study of ceruletide in the treatment of schizophrenia. American Journal of Psychiatry 142:1482–84. [rNRS]Google ScholarPubMed

Matthysse, S. (1973) Antipsychotic drug actions: A clue to the neuropathology of schizophrenia? Federation Proceedings 32:200–205. [GFA]Google Scholar

Mayeux, R., Stern, Y., Rosen, J. & Leventhal, J. (1981) Depression, intellectual impairment, and Parkinson's disease. Neurology 31:645–50. [aNRS]CrossRefGoogle Scholar

McCabe, M. S., Fowler, R. C., Cadoret, R. J. & Winokur, G. (1972) Symptom differences in schizophrenia with good and poor prognosis. American Journal of Psychiatry 128:1239–43. [AEK]CrossRefGoogle ScholarPubMed

McGeer, P. L. & McGeer, E. G. (1980) Chemistry of mood and emotion. Annual Review of Psychology 31:273–307 [GFA]CrossRefGoogle ScholarPubMed

McGeer, E. G., Staines, W. A. & McGeer, P. L. (1984) Neurotransmitters ir the basal ganglia. Canadian Journal of Neurological Science 11:89–99. [AW]CrossRefGoogle Scholar

Mclntyre, D. C. & Racine, R. J. (1986) Kindling mechanisms: Current progress on an experimental epilepsy model. Progress in Neurobiology 27:1–12. [ELG]CrossRefGoogle Scholar

Mclntyre, I. M., Kuhn, C., Demitriou, S., Fucek, F. R. & Stanley, M. (1983) Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine. Psychopharmacology 81:150–54. [aNRS]CrossRefGoogle Scholar

McLennan, H. & York, D. H. (1967) The action of dopamine on neurons of the caudate nucleus. Journal of Physiology-London 189:393–402. [rNRS]CrossRefGoogle ScholarPubMed

Meltzer, H. Y. (1979) Biology of schizophrenia subtypes: A review and proposal for method of study. Schizophrenia Bulletin 5:460–78. [AW]CrossRefGoogle ScholarPubMed

Mesulam, M. M., Mufson, E. J., Levey, A. I. & Wainer, B. H. (1983) Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basatis (substantia innominata), and hypothalamus in the rhesus monkey. Journal of Comparative Neurology 214:170–97. [aNRS]CrossRefGoogle ScholarPubMed

Mindham, R. H. S. (1970) Psychiatric symptoms in parkinsonism. Journal of Neurological Psychiatry 33:188–91. [rNRS]CrossRefGoogle ScholarPubMed

Mogenson, G. J., Jones, D. L. & Yim, C. Y. (1980) From motivation to action: Functional interface between the limbic system and the motor system. Progress in Neurobiology 14:69–97. [PMB]CrossRefGoogle ScholarPubMed

Mogenson, G. J. & Nielson, M. A. (1982) Evidence that an accumbens to subpallidal GABAergic projection contributes to locomotor activity. Brai Research Bulletin 11:309–14. [rNRS]CrossRefGoogle Scholar

Mogenson, G. J., Swanson, L. W. & Wu, M. (1983) Neural projections fron the nucleus accumbens to globus pallidus, substantia innominata, and lateral preoptic-lateral hypothalamic area: An anatomical and electrophysiological investigation in the rat. Journal of Neuroscience Research 3:189–202. [arNRS, ARC]CrossRefGoogle Scholar

Morihisa, J. M. & McAnulty, G. B. (1985) Structure and function: Brain electrical activity mapping and computerized tomography of schizophrenia. Biological Psychiatry 20:3–19. [GEJ]CrossRefGoogle ScholarPubMed

Morrison, J. H. & Magistretti, P. J. (1983) Monoamines and peptides in cerebral cortex: Contrasting principles of cortical organization. Trends in Neuroscience 6:146–51. [aNRS]CrossRefGoogle Scholar

Mowrer, O. H. (1960) Learning theory and behavior. Wiley. [JAG]CrossRefGoogle Scholar

Mueser, K. T. & Dysken, M. W. (1983) Narcotic antagonists in schizophrenia: A methodological review. Schizophrenia Bulletin 9:213–25. [PWK]CrossRefGoogle Scholar

Müller, H. F. (1985) Prefrontal cortex dysfunction as a common factor in psychosis. Acta Psychiatrica Scandinavica 71:431–40. [aNRS]CrossRefGoogle ScholarPubMed

Murphy, D. L., Brodie, H. K. H., Goodwin, F. K. & Bunney, W. E. Jr, (1971) Regular induction of hypomania by L-DOPA in “bipolar” manicdepressive patients. Nature 299:135. [aNRS]CrossRefGoogle Scholar

Murphy, D. L., Goodwin, F. K. & Bunney, W. E. Jr (1975) The psychobiology of mania. In: American handbook of psychiatry, (Vol. 6 D), ed. Hamburg, D. & Brodie, H. K. H.. Basic Books. [aNRS]Google Scholar

Nauta, W. J. H. (1971) The problem of the frontal lobe: A reinterpretation. Journal of Psychiatric Research 8:167–87. [arNRS]CrossRefGoogle ScholarPubMed

Circuitous connections linking cerebral cortex, limbic system, and corpus striatum. In: The limbic system: Functional organization and clinical disorders, ed. Foane, B. K. & Livingston, K. E.. Raven Press. [AW]Google Scholar

Nauta, W. J. H., Smith, G. P., Domesick, V. B. & Faull, R. L. M. (1978) Efferent connections and nigral afferents of the nucleus accumbens septi in the rat. Neuroscience 3:385–401. [aNRS]CrossRefGoogle ScholarPubMed

Nelson, J. C. & Charney, D. S. (1983) The symptoms of major depressive illness. American Journal of Psychiatry 138:1–13. [aNRS]Google Scholar

Nemeroff, C. B., Widerlov, E., Bissette, G., Walleus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T. & Vale, W. (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342–43. [aNRS]CrossRefGoogle ScholarPubMed

Nurse, B., Russell, V. A. & Taljaard, J. J. F. (1985) Effect of chronic desipramine treatment on adrenoceptor modulation of [3H] dopamine release from rat nucleus aecumbens slices. Brain Research 334:235–42. [arNRS, PMB]CrossRefGoogle ScholarPubMed

Oberg, R. G. E. & Divac, I. (1981) The basal ganglia and the control of movement. Trends in Neurosciences 4:122–24. [GFA]CrossRefGoogle Scholar

Pandya, D. N. & Kuypers, H. G. J. M. (1969) Cortico-cortical connections in the rhesus monkey. Brain Research 13:13–36. [aNRS]CrossRefGoogle ScholarPubMed

Parant, R. (1881) Ann. med-Psychol., quoted by Mjones, H. (1949) In: Paralysis agitans. (Acta psychiat. neurol., suppl. 54Munksgaard, Copenhagen. [rNRS]Google Scholar

Pardes, H. (1986) Neuroscience and psychiatry: Marriage or coexistence? The American Journal of Psychiatry 143:1205–12. [MLM]Google ScholarPubMed

Park, M. R., Lighthall, J. W. & Kitai, S. T. (1980) Recurrent inhibition in the rat neostriatum. Brain Research 194:359–69. [AAG]CrossRefGoogle ScholarPubMed

Patrick, H. I. & Levy, D. M. (1922) Parkinson's disease: A clinical study of 146 cases. Archives of Neurological Psychiatry (Chicago) 7:711–20. [rNRS]CrossRefGoogle Scholar

Penney, J. B. & Young, A. B. (1981) GABA as the pallidothalamic neurotransmitter: Implications for basal ganglia function. Brain Research 207:195–99. [aNRS]CrossRefGoogle ScholarPubMed

Penney, J. B. & Young, A. B. (1983) Speculations on the functional anatomy of basal ganglia disorders. Annual Review of Neuroscience 6:73–94. [arNRS, PmB]CrossRefGoogle ScholarPubMed

Penney, J. B. & Young, A. B. (1986) Striatal inhomogeneities and basal ganglia function. Movement Disorders 1:3–15. [ARC]CrossRefGoogle ScholarPubMed

Perez-Rincon, H., Alvarez-Rueda, J. M. & de la Vega, M. A. (1981) Nomifensine in the treatment of depression: A long term controlled trial. Current Therapeutic Research-Clinical Experimental 29:327–34. r[NRS]Google Scholar

Perry, T. L., Hansen, S. & Kloster, M. (1973) Huntington's chorea: Deficiency of aminobutyric acid in brain. New England Journal of Medicine 288:337–42. [JRS]CrossRefGoogle ScholarPubMed

Pert, A. & Bunney, W. E. Jr (1982) Chronic lithium modulates receptor sensitivity. In: Basic mechanisms in the action of lithium, ed. Emrieh, H. M., Aldenhoff, J. B. & Lux, H. D.. Excerpta Medica. [arNRS]Google Scholar

Pert, A., Rosenblatt, J. E., Sivit, C., Pert, C. B. & Bunney, W. E. (1978) Long term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201:171–73. [aNRS]CrossRefGoogle ScholarPubMed

Pert, A. & Sivit, C. (1977) Neuroanatomical focus for morphine and enkephalin-induced hypermotility. Nature 265:645–47. [PWK]CrossRefGoogle ScholarPubMed

Peselow, E., Angrist, B., Sudilovsky, A., Corwin, J., Siekierski, J., Trent, F. & Rotrosen, J. (1987) Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophrenia. Psychopharmacology 91:80–84. [rNRS]CrossRefGoogle ScholarPubMed

Petit, H. O., Ettenberg, A., Bloom, F. E. & Koob, G. F. (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology 84:167–73. [AEK]CrossRefGoogle Scholar

Phillips, A. G. (1984) Brain reward circuitry: A case for separate systems. Brain Research Bulletin 12:195–201. [AP]CrossRefGoogle ScholarPubMed

Pitman, R. K., Kolb, B., Orr, S. P. & Singh, M. M. (1987) Ethological study of facial behavior in nonparanoid and paranoid schizophrenics. American Journal of Psychiatry 144:99–102. [BK]Google Scholar

Pittman, K. J., Jakubovic, A. & Ribiger, H. C. (1984) The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology 82:371–77. [aNRS]CrossRefGoogle ScholarPubMed

Poncelet, M., Dangoumau, L., Soubrié, P. & Simon, P. (in press) Effects of neuroleptic drugs, clonidine and lithium on the expression of conditioned behavioral excitation in rats. Psychopharmacology. [PS]Google Scholar

Pope, H. G. Jr, & Lipinski, J. F. (1978) Diagnosis in schizophrenia and manic-depressive illness. Archives of General Psychiatry 35:811–28. [aNRS, AEK]CrossRefGoogle ScholarPubMed

Porsolt, R. D. (1981) Behavioural despair. In: Antidepressants: Neurochemical, behavioural and clinical perspectives, ed. Enna, S. J., Malick, J. B. & Richelson, E.. Raven Press. [arNRS]Google Scholar

Porsolt, R. D., Anton, G., Blavet, N. & Jalfre, M. (1978) Behavioural despair in rats: A new model sensitive to antidepressant treatments. European Journal of Pharmacology 47:379–91. [aNRS]CrossRefGoogle ScholarPubMed

Porsolt, R. D., Bertin, A., Blavet, N., Deniel, M. & Jalfre, M. (1979) Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity. European Journal of Pharmacology 57:201–10. [aNRS]CrossRefGoogle ScholarPubMed

Porsolt, R. D., Le Pichon, M. & Jalfre, M. (1977) Depression: A new animal model sensitive to antidepressant treatments. Nature 266:730–32. [aNRS]CrossRefGoogle ScholarPubMed

Post, R. M., Ballenger, J. C. & Goodwin, F. K. (1980) Cerebrospinal fluid studies of neurotransmitter function in manic and depressive illness. In: Neurobiology of cerebrospinal fluid, ed. Wood, J. H.. Plenum. [arNRS]Google Scholar

Post, R. M., Gerner, R. H., Carman, J. S., Gillin, J. C., Jimerson, D. C., Goodwin, F. K. & Bunney, W. E. Jr, (1978) Effects of a dopamine agonist piribedil in depressed patients. Archives of General Psychiatry 35(5):609–15. [aNRS]CrossRefGoogle ScholarPubMed

Post, R. M. & Jimerson, D. C. (1982) Dopaminergic mechanism in affective illness. Symposium on special aspects of psychopharmacology. SainteMaxime, France. [arNRS]Google Scholar

Post, R. M., Jimerson, D. C., Bunney, W. E. Jr, & Goodwin, F. K. (1980) Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology 67:297. [aNRS]CrossRefGoogle ScholarPubMed

Price, L. H., Charney, D. S., Rubin, , & Heninger, G. R. (1986) Alpha-2 adrenergic receptor function in depression. Archives of General Psychiatry 43:849–58. [AW]CrossRefGoogle ScholarPubMed

Pycock, C. J., Kerwin, R. W. & Carter, C. J. (1980a) Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex on neurotransmitter systems in subcortical sites in the rat. Journal of Neurochemistry 34:91–99. [PMB, PS, JPT]CrossRefGoogle ScholarPubMed

Pycock, C. J., Kerwin, R. W. & Carter, C. J. (1980b) Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286:74–77. [GEJ]CrossRefGoogle ScholarPubMed

Quitkin, F., Rifkin, A. & Klein, D. F. (1979) Monoamine oxidase inhibitors: A review of antidepressant effectiveness. Archives of General Psychiatry 36:749–60. [aNRS]CrossRefGoogle ScholarPubMed

Randrup, A., Munkvad, I., Fog, R., Gerlach, J., Molander, L., Kjeilberg, B. & Scheel-Kruger, J. (1975) Mania, depression and brain dopamine. In: Current developments in psychopharmacology, Vol. 2, ed. Essman, W. B. & Valzelli, L.. Spectrum. [aNRS]Google Scholar

Reches, A., Jackson-Lewis, V. & Fahn, S. (1984) Lithium does not interact with haloperidol in the dopaminergic pathways of the brain. Psychopharmacology 82:330–34. [aNRS]CrossRefGoogle ScholarPubMed

Redmond, D. E. Jr, (1979) New and old evidence for the involvement of a brain norepinephrine system in anxiety. In: Phenomenology and treatment of anxiety, ed. Fann, W. G., Karacan, I., Pokorny, A. D., & Williams, R. L.. Spectrum. [JAG]Google Scholar

Reibaud, M., Blanc, G., Studler, J-M., Glowinski, J., Tassin, J-P. (1984) Nondopaminergic prefronto-cortical efferents modulate Dl receptors in the nucleus accumbens. Brain Research 305:43–50. [PMB, GEJ, JPT]CrossRefGoogle Scholar

Reynolds, G. P. (1983) Increased concentrations and lateral asymmetry of amygdala dopamine in schizophrenia. Nature 305:827–30. [MLM]CrossRefGoogle ScholarPubMed

Richelson, E. & Pfenning, M. (1984) Blockade by anti-depressant and related compounds of biogenic amine uptake into rat brain synaptosomes: Most anti-depressants selectively block norepinephrine uptake. European Journal of Pharmacology 104:227–86. [aNRS]CrossRefGoogle Scholar

Risch, S. C., Kalin, N. H., Cohen, R. M., Wecker, J., Insel, T. R., Cohen, M. L. & Murphy, D. L. (1981) Muscarinic cholinergic influences on ACTH and B-endorphin release mechanisms in human subjects. Peptides 2:95–97. [arNRS]CrossRefGoogle ScholarPubMed

Risch, S. C., Kalin, N. H. & Janowsky, D. S. (1981) Cholinergic challenges in affective illness: Behavioral and neuroendocrine correlates. Journal of Clinical Psychopharmacology 1:186–92. [aNRS]CrossRefGoogle ScholarPubMed

Robbins, A. H. (1976) Depression in patients with parkinsonism. British Journal of Psychiatry 128:141–45. [rNRS]CrossRefGoogle Scholar

Robbins, T. W., Evenden, J. L., Ksir, C., Reading, P., Wood, S. & Carli, M. (1986) The effects of d-amphetamine, alpha-flupenthixol, and mesolimbic dopamine depletion on a test of attentional switching in the rat. Psychopharmacology 90:72–78. [ARC]CrossRefGoogle ScholarPubMed

Robbins, T. W. & Everitt, B. J. (1982) Functional studies of the central catecholamines. International Review of Neurobiology 23:303–65. [AEK]CrossRefGoogle ScholarPubMed

Robbins, T. W. & Koob, G. F. (1980) Selective disruption of displacement behaviour by lesions of the mesolimbic dopamine system. Nature 285:409–12. [arNRS]CrossRefGoogle ScholarPubMed

Roberts, D. C. S., Corcoran, M. E. & Fibiger, H. C. (1977) On the role of ascending catecholamine systems in intravenous self-administration of cocaine. Pharmacology, Biochemistry and Behavior 6:615–20. [arNRS]CrossRefGoogle ScholarPubMed

Roberts, D. C. S., Koob, G. F., Klonoff, P. & Fibiger, H. C. (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacology, Biochemistry and Behavior 12:781–87. [aNRS]CrossRefGoogle ScholarPubMed

Roberts, D. C. S., Zis, A. P. & Fibiger, H. C. (1975) Ascending catecholamine pathways and amphetamine induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine. Brain Research 93:441–54. [rNRS]CrossRefGoogle ScholarPubMed

Robinson, T. G. & Beart, P. M. (in press) Excitotoxic lesions reveal excitant amino acid projections to the nucleus accumbens septi from the basolateral nucleus of the amygdala and the parataenial nucleus of the thalamus in the rat. Neurosdence Letters. [PMB]Google Scholar

Rolls, E. T. (1984) Responses of neurons in different regions of the striatum of the behaving monkey. In: The basal ganglia: Structure and function, ed. McKenzie, S. S., Kenn, R. E. & Wilcock, L. N.. Plenum. [arNRS]Google Scholar

Rolls, E. T., Ashton, J., Williams, G., Thorpe, S. J., Mogenson, G. J., Colpaert, F. & Phillips, A. G. (1982) Neural activity in the ventral striatum of the behaving monkey. Proceedings of the Society of Neuroscience 8:169. [aNRS]Google Scholar

Rolls, E. T., Thorpe, S. J., Boytim, M., Szabo, I. & Perrett, D. I. (1984) Responses of striatal neurons in the behaving monkey. 3. Effects of iontophoretically applied dopamine on normal responsiveness. Neuroscience 12:1201–12. [rNRS]CrossRefGoogle ScholarPubMed

Roth, M. (1979) A classification of affective disorders based on a synthesis of new and old concepts. In: Research in the psychobiology of human behavior, ed. Meyer, E. III & Brady, I. V.. Johns Hopkins University Press. [JAG]Google Scholar

Russchen, F. T., Bakst, I., Amaral, D. G. & Price, J. L. (1985) The amygdalostriatal projections in the monkey: An anterograde tracing study. Brain Research 329:241–57. [AEK]CrossRefGoogle ScholarPubMed

Rylander, G. (1969) Clinical and medico-criminological aspects of addictions to central stimulatory drugs. In: Abuse of central stimulants, ed. Sjoquist, F. & Tottie, M.. Raven Press. [aNRS, DLC]Google Scholar

Santamaria, J., Tolosa, E. & Valles, A. (1986) Parkinson's disease with depression: A possible subgroup of idiopathic parkinsonism Neurology 36:1130–33. [rNRS]CrossRefGoogle ScholarPubMed

Scheel-Kruger, J. (1983) The GABA receptor and animal behavior. In: GABA receptors, ed. Enna, S. J.. Humana Press. [ARC]Google Scholar

Scheel-Kruger, J. (1986) Dopamine-GABA interactions: Evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system. Acta Neurologica Scandinavica 73, Supplementum 107. [ARC]Google Scholar

Schildkraut, J. (1965) Catecholamine hypothesis of affective disorders. American Journal of Psychiatry 122:509–22. [aNRS]CrossRefGoogle ScholarPubMed

Schildkraut, J. (1970) Neuropsychopharmacology and the affective disorders. Little Brown. [aNRS]Google Scholar

Schutz, R. A., Schutz, M. T. B., Orsingher, O. A. & Izquierdo, I. (1979) Brain dopamine and noradrenaline levels in rats submitted to four different aversive tasks. Psychopharmacology 63:289–92. [aNRS]CrossRefGoogle Scholar

Schwab, R. S. & England, A. C. (1958) Parkinson's disease. Journal of Chronic Diseases 8:488–509. [rNRS]CrossRefGoogle ScholarPubMed

Schwaber, J. S., Kapp, B. S., Higgins, G. A. & Rapp, P. R. (1982) Amygdaloid and basal forebrain direct connections with the nucleus of the solitary tract and the dorsal motor nucleus. Journal of Neuroscience Research 2:1424–38. [GFA]CrossRefGoogle ScholarPubMed

Seeman, P. (1981) Dopamine receptors in post-mortem schizophrenic brains. Lancet 2:1130. [arNRS]Google Scholar

Seeman, P., Ulpian, C., Bergeron, G., Riederer, P., Jellinger, K., Gabriel, E., Reynolds, G. P. & Tourtellotte, W. W. (1984) Bimodal distribution of dopamine receptor densities in brains of schizophrenics. Science 225:728–31. [arNRS]CrossRefGoogle ScholarPubMed

Seligman, M. E. P. (1975) Helplessness; On depression, development, and death. Freeman. [aNRS]Google Scholar

Shelton, R. C., Doran, A. J., Pickar, D. & Weinberger, D. R. (1985) Cerebral structural pathology in schizophrenia: A new cohort. Abstracts: Proceedings of the World Congress of Biological Psychiatry, Philadelphia, 09. [GEJ]Google Scholar

Shelton, R. C. & Weinberger, D. R. (1986) X-ray computerized tomography studies in schizophrenia: A review and synthesis. In: The neurology of schizophrenia, ed. Nasrallah, H. & Weinberger, D. R.. Elsevier. [GEF]Google Scholar

Sherman, A. D. & Petty, F. (1982) Specificity of the learned helplessness animal model of depression. Pharmacology, Biochemistry and Behavior 16:449–54. [JAG]CrossRefGoogle Scholar

Siegel, C., Waldo, M., Mizner, G., Adler, L. E. & Freedman, R. (1984) Deficits in sensory gating in schizophrenic patients and their relatives. Archives of General Psychiatry 41:607–13. [rNRS]CrossRefGoogle ScholarPubMed

Siggins, G. R. (1978) Electrophysiological role of dopamine in striatum: Excitatory or inhibitory. In: Psychopharmacology: A generation of progress, ed. Upton, M. A., Mascio, A. Di & Killam, K. F.. Raven Press. [rNRS]Google Scholar

Siggins, G. R., Hoffer, B. J. & Ungerstedt, O. (1974) Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons. Life Sciences 15:779–92. [rNRS]CrossRefGoogle ScholarPubMed

Sitaram, N. & Gershon, S. (1983) From animal models to clinical testing – promises and pitfalls. Progress in Neuro-Psychopharmacology and Biological Psychiatry 7:227–28. [PS]CrossRefGoogle ScholarPubMed

Sitaram, N., Gillin, J. C. & Bunney, W. E. Jr (1984) Cholinergic and catecholaminergic receptor sensitivity in affective illness: Strategy and theory. In: Neurobiology of mood disorders, ed. Post, R. M. & Ballenger, J. C.. Williams and Wilkins. [aNRS]Google Scholar

Snyder, S. H. (1972) Catecholamines in the brain as mediators of amphetamine psychosis. Archives of General Psychiatry 27:169–79. [aNRS]CrossRefGoogle ScholarPubMed

Solomon, P. R., Crider, A., Winkelman, J. W., Turi, A., Kamer, R. M. & Kaplan, L. J. (1981) Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced super-sensitivity-relationship to schizophrenic attention disorder. Biological Psychiatry 16:519–37. [JAG]Google ScholarPubMed

Solomon, P. R. & Staton, D. M. (1982) Differential effects of micro injections of d-amphetamine into the nucleus accumbens or the caudate putamen on the rat's ability to ignore an irrelevant stimulus. Biological Psychiatry 17:743–56. [JAG]Google ScholarPubMed

Spyraki, C., Fibiger, H. C. & Phillips, A. G. (1982) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Research 253:185–93. [aNRS]CrossRefGoogle ScholarPubMed

Staunton, D. A., Magistretti, P. J., Shoemaker, W. J. & Bloom, F. E. (1982) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum: I. Locomotor activity and behavioral supersensitivity. Brain Research 232:391–400. [aNRS]CrossRefGoogle ScholarPubMed

Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., Deyo, S. N. & Bloom, F. E. (1982) Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum: II. No effect on denervation or neurolepticinduced supersensitivity. Brain Research 232:401–12. [aNRS]CrossRefGoogle ScholarPubMed

Stein, L. & Wise, C. D. (1971) Possible aetiology of schizophrenia: Progressive damage to the noradrenergic reward system by 6-hydroxydopamine. Science 171:1032–36. [aNRS]CrossRefGoogle Scholar

Stern, Y. & Langston, J. W. (1985) Intellectual changes in patients with MPTP-induced parkinsonism. Neurology 35:1506–9.[aNRS]CrossRefGoogle ScholarPubMed

Sternberg, D. E., Bowers, M. B. Jr, Heninger, G. R. & Charney, D. S. (1983) Lithium prevents adaptation of brain dopamine systems to haloperidol in schizophrenic patients. Psychiatry Research 10:79–86. [aNRS]CrossRefGoogle ScholarPubMed